Johnson Investment Counsel’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,476
| Closed | -$162K | – | 734 |
|
|
2023
Q3 | $162K | Sell |
10,476
-485
| -4% | -$7.5K | ﹤0.01% | 645 |
|
|
2023
Q2 | $172K | Sell |
10,961
-67
| -0.6% | -$1.05K | ﹤0.01% | 644 |
|
|
2023
Q1 | $182K | Sell |
11,028
-251
| -2% | -$4.14K | ﹤0.01% | 634 |
|
|
2022
Q4 | $176K | Sell |
11,279
-101
| -0.9% | -$1.58K | ﹤0.01% | 634 |
|
|
2022
Q3 | $148K | Buy |
11,380
+101
| +0.9% | +$1.31K | ﹤0.01% | 619 |
|
|
2022
Q2 | $158K | Buy |
11,279
+1,006
| +10% | +$14.1K | ﹤0.01% | 627 |
|
|
2022
Q1 | $147K | Sell |
10,273
-400
| -4% | -$5.72K | ﹤0.01% | 648 |
|
|
2021
Q4 | $145K | Sell |
10,673
-3,927
| -27% | -$53.4K | ﹤0.01% | 650 |
|
|
2021
Q3 | $239K | Sell |
14,600
-819
| -5% | -$13.4K | ﹤0.01% | 588 |
|
|
2021
Q2 | $266K | Sell |
15,419
-378
| -2% | -$6.52K | ﹤0.01% | 558 |
|
|
2021
Q1 | $288K | Sell |
15,797
-517
| -3% | -$9.43K | ﹤0.01% | 513 |
|
|
2020
Q4 | $297K | Sell |
16,314
-75
| -0.5% | -$1.37K | ﹤0.01% | 498 |
|
|
2020
Q3 | $292K | Sell |
16,389
-196
| -1% | -$3.49K | 0.01% | 479 |
|
|
2020
Q2 | $304K | Buy |
16,585
+80
| +0.5% | +$1.47K | 0.01% | 480 |
|
|
2020
Q1 | $251K | Hold |
16,505
| – | – | 0.01% | 479 |
|
|
2019
Q4 | $326K | Buy |
16,505
+200
| +1% | +$3.95K | 0.01% | 492 |
|
|
2019
Q3 | $280K | Buy |
+16,305
| New | +$280K | 0.01% | 514 |
|